| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |